107 filings
6-K
NYXH
Nyxoah S.A.
2 Jan 25
Current report (foreign)
4:05pm
6-K
NYXH
Nyxoah S.A.
13 Dec 24
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
4:10pm
6-K
NYXH
Nyxoah S.A.
2 Dec 24
Information on the total number of voting rights and shares
4:10pm
6-K
NYXH
Nyxoah S.A.
20 Nov 24
Current report (foreign)
4:21pm
6-K
NYXH
Nyxoah S.A.
18 Nov 24
Current report (foreign)
4:42pm
S-8
dwj czqvmvr4b8s0
8 Nov 24
Registration of securities for employees
4:44pm
6-K
ajx81ahn
6 Nov 24
Nyxoah Reports Third Quarter Financial and Operating Results
4:11pm
6-K
hd4q z1zg
5 Nov 24
Nyxoah Appoints John Landry as Chief Financial Officer
4:10pm
6-K
r37lbrzcr 5x607ncwsg
28 Oct 24
Current report (foreign)
4:15pm
6-K
4o1eu t69o6ux
15 Oct 24
Current report (foreign)
4:45pm
6-K
v63s3pw 273
9 Oct 24
Current report (foreign)
4:37pm
6-K
lma7x
7 Oct 24
Nyxoah Raises $27 Million through its At-the-Market Offering
5:24pm
6-K
cj79 upxo4734la1nct9
27 Sep 24
Current report (foreign)
6:09pm
6-K
onhg uwu6r
6 Aug 24
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
4:14pm
6-K
mx7gouza2v
17 Jul 24
Nyxoah Appoints Scott Holstine as Chief Commercial Officer
4:05pm
6-K
ql3kie
5 Jul 24
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank
4:05pm
6-K
jxleha9
1 Jul 24
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
4:10pm
6-K
916gabgk4b1va
28 Jun 24
Information on the total number of voting rights and shares
6:46pm
6-K
31qrvfzv3
3 Jun 24
Current report (foreign)
4:24pm
6-K
ljpb1qoe1
31 May 24
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
4:05pm